
For investors who favor exchange-traded funds (ETFs), the market has never been more dynamic. Not only do ETFs now outnumber individual stocks, but the sheer versatility of today's funds allows invest

Intuitive Surgical, Inc. has declined 38% since my previous Hold, driven by valuation concerns and recent structural headwinds. Despite ISRG's Q2 2026 earnings growth, margin expansion, and raised gu

Intuitive Surgical TodayISRGIntuitive Surgical$345.42 -56.91 (-14.15%) As of 07/17/2026 04:00 PM Eastern52-Week Range$344.55▼$603.88P/E Ratio39.57Price Target$523.46Add to WatchlistIntuitive Surgical
Intuitive Surgical (NASDAQ: ISRG) reported a solid second quarter of 2026, with management pointing to continued global adoption of its da Vinci, da Vinci SP and Ion platforms, even as U.S. procedure
Intuitive Surgical remains a buy despite a nearly 30% stock decline and post-earnings volatility. Adoption metrics are resilient, with strong system placements and installed base growth offsetting sof
Intuitive Surgical, Inc. remains a compelling long-term compounder, with operational improvements and robust growth prospects despite recent market headwinds. ISRG delivered solid Q2 results: revenue
Intuitive Surgical Inc. (NASDAQ:ISRG) stock fell sharply Friday after the company reaffirmed its 2026 da Vinci procedure growth outlook but flagged slowing U.S. procedure trends and insurance-related
Intuitive Surgical (NASDAQ: ISRG) shares fell about 11% on Friday after the robotic surgery company reported second-quarter results that topped Wall Street expectations but disappointed investors with
Intuitive Surgical Inc. (NASDAQ:ISRG) posted better-than-expected second-quarter results after Thursday's closing bell.

Intuitive Surgical, Inc. (ISRG) Q2 2026 Earnings Call Transcript
Intuitive Surgical NASDAQ: ISRG reported a solid second quarter of 2026, with management pointing to continued global adoption of its da Vinci, da Vinci SP and Ion platforms, even as U.S. procedure gr
Intuitive Surgical Inc. (NASDAQ:ISRG) posted its second-quarter results after Thursday's closing bell, beating analyst estimates on the top and bottom lines. Here's a look at the details inside the re